Mitochondrial Medicine: Pharmacological Targeting of Mitochondria in Disease—2nd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (20 March 2025) | Viewed by 2003
Special Issue Editors
Interests: cell differentiation; cancer; cancer cell metabolism; mitochondria; mitochondrial metabolism; oxidative phosphorylation; tumor markers; Warburg effect
Special Issues, Collections and Topics in MDPI journals
Interests: cancer; biomarkers; mitochondria; target drugs; clinical chemistry; laboratory medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This is a continued series of the hot topic of Mitochondrial Medicine: Pharmacological Targeting of Mitochondria in Disease; our first Special Issue of this topic received interesting contributions and discussions (https://www.mdpi.com/journal/ijms/special_issues/Mitochondrial_Medicine).
Mitochondria are fundamental organelles in cell biology. They can no longer be considered simply the powerhouse of the cell because this fundamental function is strictly related to different activities of the cell (apoptosis, signal transduction, thermogenesis, proliferation, differentiation, and so on). Experimental research gives some light to molecular mechanisms at the basis of these complex and interconnected functions with significant advances in knowledge of the etiopathogenesis, pathophysiology, and therapeutic approaches of different diseases. Importantly, these different pathologies are not limited to typical mitochondrial disorders but affect a wide range of acute and chronic diseases (i.e., ischemic disorders, infectious diseases, neurodegenerative diseases, infertility, psychotic disorder, dermopathies, sepsis, and above all, cancer). The growing pathophysiological role of mitochondria is further demonstrated by the number of clinical studies, recorded by ClinicalTrials.gov, showing mitochondria in their keywords panel (at present, more than 1500 clinical studies).
To date, the pharmacology of mitochondria includes molecules which can enrich the NAD+ pool and/or “stimulate” oxidative metabolism (i.e., carnitine), molecules that protect these organelles by the end products of their oxidative metabolism (i.e., Q10, mitoQ, dicumarols and son on); however, some interesting new drugs are now under evaluation.
Last but not least, some intriguing parmacotoxicological aspects, too often neglected, on mitochondria, as innocent bystanders, are well-known (fibrates, statins, reverse-transcriptase inhibitors). All these data further push to deepen our understanding of and promote such a fascinating, innovative, and promising therapeutic approach.
This Special Issue focuses on the research field of the pharmacology of mitochondria; Original research articles, short communications, and reviews, both narrative and systematic, are all welcome for submission to this Special Issue.
Dr. Patrizia Bottoni
Prof. Dr. Roberto Scatena
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- complex I (NADH: ubiquinone oxidoreductase)
- drug toxicity
- mitochondria
- reactive oxygen species (ROS)
- therapeutic drug monitoring
- cancer stem cells
- cancer cell differentiation
- cancer cell metabolism
- cancer diagnosis
- cancer therapy
- complex I
- oxidative phoshorylation
- tumor markers
- Warburg effect
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
